This webinar is recorded live and the sessions are available for delegates to access freely for six months once uploaded to our e-Learning platform.
*Please note we endeavour to upload content as quickly as possible after each conference, but it typically takes 1-2 weeks.
Join us for this FREE live 90-minute webinar focusing on focusing on the interplay between diabetes, cardiovascular disease and heart failure.
People with diabetes have at least a 2.5 fold higher risk of heart failure than those without. Heart failure is the first cardiac macrovascular complication to manifest in type 2 diabetes and 2 in 3 people with type 2 diabetes have evidence of left vetrnicular dysfuncrion within 4 years of diagnosis. Heart failure is also frequently underdiagnosed, with up to 28% of people with type 2 diabetes having undiagnosed heart failure. Yet we underestimate the impact of heart failure at our peril: mortality rates for people with diabetes and heart failure are twice as high as for those without, 1 in 2 people with type 2 diabetes and heart failure die within 5 years and survival improvements have been only modest in the last 2 decades. With newer hypoglycaemic agents proven to reduce the risk of morbidity and mortality from heart failure, it is time to rethink our approach to the management of blood glucose in type 2 diabetes.
- Understand the interplay between type 2 diabetes and the cardiovascular system, with a focus on heart failure.
- Examine the evidence for newer hypoglycaemic agents in the prevention and treatment of heart failure in type 2 diabetes.
- Recognise how to put clinical trial evidence into practice for patients at every stage of the type 2 diabetes continuum, to improve cardiovascular outcomes and protect the resources of the NHS.
There will be plenty of time in this webinar for Q&A
This webinar will be Chaired by Dr Sarah Jarvis MBE, GP and Clinical Director of Patient.info.
- Dr Yassir Javaid, Cardiovascular Clinical Lead at East Midlands Clinical Networks
- Professor Naveed Sattar, Professor and Honorary Consultant (Cardiovascular & Medical Sciences)